- Report
- February 2024
Ecuador
From €2610EUR$2,850USD£2,222GBP
From €2610EUR$2,850USD£2,222GBP
- Report
- February 2024
Denmark
From €2610EUR$2,850USD£2,222GBP
- Report
- February 2024
Czech Republic
From €2610EUR$2,850USD£2,222GBP
- Report
- February 2024
Cyprus
From €2610EUR$2,850USD£2,222GBP
- Report
- February 2024
Colombia
From €2610EUR$2,850USD£2,222GBP
- Report
- February 2024
China
From €2610EUR$2,850USD£2,222GBP
- Report
- February 2024
Chile
From €2610EUR$2,850USD£2,222GBP
- Report
- February 2024
Canada
From €2610EUR$2,850USD£2,222GBP
- Report
- February 2024
Bulgaria
From €2610EUR$2,850USD£2,222GBP
- Report
- February 2024
Brazil
From €2610EUR$2,850USD£2,222GBP
- Report
- February 2024
Bolivia
From €2610EUR$2,850USD£2,222GBP
- Report
- February 2024
Belgium
From €2610EUR$2,850USD£2,222GBP
- Report
- February 2024
Belarus
From €2610EUR$2,850USD£2,222GBP
- Report
- February 2024
Bangladesh
From €2610EUR$2,850USD£2,222GBP
- Report
- February 2024
Bahrain
From €2610EUR$2,850USD£2,222GBP
- Report
- February 2024
Austria
From €2610EUR$2,850USD£2,222GBP
- Report
- February 2024
Australia
From €2610EUR$2,850USD£2,222GBP
- Report
- February 2024
Argentina
From €2610EUR$2,850USD£2,222GBP
- Report
- February 2024
Albania
From €2610EUR$2,850USD£2,222GBP

High-sensitivity C-reactive protein (HS CRP) is a biomarker used in diagnostics to measure inflammation in the body. It is a protein produced by the liver in response to inflammation and is used to detect and monitor conditions such as cardiovascular disease, rheumatoid arthritis, and other inflammatory diseases. HS CRP tests are used to assess the risk of developing cardiovascular disease and to monitor the effectiveness of treatments.
HS CRP tests are available in a variety of formats, including point-of-care tests, laboratory tests, and home tests. Point-of-care tests are used to provide rapid results in a clinical setting, while laboratory tests are used to provide more accurate results. Home tests are used to provide convenient testing for patients who are unable to access a clinical setting.
Some companies in the HS CRP market include Abbott, Roche, Siemens, and Beckman Coulter. Show Less Read more